Cubist Systematic Strategies, LLC Revance Therapeutics, Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$5.81 - $11.2 $38,346 - $73,920
-6,600 Reduced 29.33%
15,900 $139,000
Q3 2023

Nov 14, 2023
BUY
$11.47 - $25.07 $108,965 - $238,165
9,500 Added 73.08%
22,500 $258,000
Q2 2023

Aug 14, 2023
SELL
$24.7 - $37.61 $143,260 - $218,138
-5,800 Reduced 30.85%
13,000 $329,000
Q1 2023

May 15, 2023
BUY
$18.36 - $35.27 $345,168 - $663,076
18,800 New
18,800 $605,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email